表紙
市場調査レポート

世界におけるメタボロミクス市場

Global Metabolomics Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 258444
出版日 ページ情報 英文 86 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
世界におけるメタボロミクス市場 Global Metabolomics Market 2014-2018
出版日: 2014年07月14日 ページ情報: 英文 86 Pages
概要

世界のメタボロミクス市場は2013〜2018年にかけ、CAGR24.26%で拡大すると予測されています。メタボロミクスは新たな実験技術として、生物学や医学、環境科学に広く用いられています。

当レポートでは、世界のメタボロミクス市場について調査し、地域別動向、2018年までの市場成長見通しと課題、ベンダーの競合動向とプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語

第3章 当レポートの範囲

第4章 市場調査方法

第5章 イントロダクション

第6章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 技術別市場セグメンテーション

第8章 用途別市場セグメンテーション

第9章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 購買基準

第11章 市場成長促進因子

第12章 促進因子とその影響

第13章 市場の課題

第14章 促進因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー環境

  • 競合シナリオ
    • 主なニュース
    • 合併・買収
    • 市場シェア分析
    • その他の注目すべきベンダー

第18章 主要ベンダー分析

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker
  • Human Metabolome Technologies
  • Metabolon Inc.

第19章 このシリーズの他のレポート

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR3797

About Metabolomics

Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism. Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics.

TechNavio's analysts forecast the Global Metabolomics market will grow at a CAGR of 24.26 percent over the period 2013-2018.

Covered in this Report

The Global Metabolomics market can be divided into eight segments: Mass Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, High Performance Liquid Chromatography, Metabolomics-on-a-chip, Fourier-Transform Infrared Spectroscopy, Capillary Electrophoresis, and Electrochemical Array. These are the sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.

TechNavio's report, the Global Metabolomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Metabolomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Human Metabolome Technologies Inc.
  • Metabolon Inc.

Other Prominent Vendors

  • Acadia Pharmaceuticals
  • Accelrys
  • BG Medicine
  • Biocrates Life Sciences
  • Chenomx
  • Life Technologies
  • Metabolomic Technologies
  • Nanosyn
  • PerkinElmer
  • Waters

Key Market Driver

  • Increase in Prevalence of Cancer and Diabetes

For a full, detailed list, view our report

Key Market Challenge

  • Quality Control Standards of Metabolic Profiling Data

For a full, detailed list, view our report

Key Market Trend

  • Emergence of Standards to Analyze Metabolomics Data

For a full, detailed list, view our report

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation

  • 09.1. Metabolomics Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Metabolomics Market in the EMEA
    • 09.2.1. Market Size and Forecast
  • 09.3. Metabolomics Market in the APAC
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Agilent Technologies
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue 2013
    • 18.1.4. Business Segmentation by Revenue 2012 and 2013
    • 18.1.5. Sales by Geography
    • 18.1.6. Business Strategy
    • 18.1.7. Key Information
    • 18.1.8. SWOT Analysis
    • 18.1.9. Strengths
    • 18.1.10. Weaknesses
    • 18.1.11. Opportunities
    • 18.1.12. Threats
  • 18.2. Bio-Rad Laboratories
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2012
    • 18.2.4. Business Segmentation by Revenue 2012 and 2011
    • 18.2.5. Geographical Segmentation by Revenue 2012
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
    • 18.2.9. Strengths
    • 18.2.10. Weakness
    • 18.2.11. Opportunities
    • 18.2.12. Threats
  • 18.3. Bruker
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview/ Description
    • 18.3.3. Business Segmentation
    • 18.3.4. Business Strategy
    • 18.3.5. Revenue Segmentation by Business /Products
    • 18.3.6. Sales by Geographical Segmentation
    • 18.3.7. Key Information
    • 18.3.8. SWOT Analysis
    • 18.3.9. Strengths
    • 18.3.10. Weaknesses
    • 18.3.11. Opportunities
    • 18.3.12. Threats
  • 18.4. Human Metabolome Technologies
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview/ Description
    • 18.4.3. Business Segmentation
    • 18.4.4. Business Strategy
    • 18.4.5. Revenue Segmentation by Business
    • 18.4.6. Sales by Geographical Segmentation
    • 18.4.7. Key Information
    • 18.4.8. SWOT Analysis
    • 18.4.9. Strengths
    • 18.4.10. Weaknesses
    • 18.4.11. Opportunities
    • 18.4.12. Threats
  • 18.5. Metabolon Inc.
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview/Description
    • 18.5.3. Business Segmentation
    • 18.5.4. Business Strategy
    • 18.5.5. Key Information
    • 18.5.6. SWOT Analysis
    • 18.5.7. Strengths
    • 18.5.8. Weaknesses
    • 18.5.9. Opportunities
    • 18.5.10. Threats

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Metabolomics Market 2013-2018 (US$ million)
  • Exhibit 3: Global Metabolomics Market Segmentation by Technology
  • Exhibit 4: Global Metabolomics Market Segmentation by Application
  • Exhibit 5: Global Metabolomics Market by Geographical Segmentation 2013
  • Exhibit 6: Global Metabolomics market by Geographical Segmentation in 2018
  • Exhibit 7: Metabolomics Market in the Americas 2013-2018 (US$ million)
  • Exhibit 8: Metabolomics market in the EMEA region 2013-2018 (US$ million)
  • Exhibit 9: Metabolomics Market in the APAC region 2013-2018 (US$ million)
  • Exhibit 10: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
  • Exhibit 11: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 12: Agilent Technologies Inc.: Sales by Geography 2013
  • Exhibit 13: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 14: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
  • Exhibit 15: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 16: Business segments for Human Metabolome Technologies
  • Exhibit 17: Revenue Segmentation of Global Metabolomics Market 2014-2018 for 2013
  • Exhibit 18: Revenue Segmentation of Global Metabolomics Market 2014-2018 by Geography for 2013
  • Exhibit 19: Metabolon Inc. Business Segmentation
Back to Top